Allstate Corporation’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.64M Sell
15,857
-980
-6% -$322K 0.05% 252
2025
Q4
$5.9M Buy
16,837
+8,445
+101% +$2.85M 0.08% 154
2025
Q3
$2.71M Buy
8,392
+7,860
+1,477% +$2.44M 0.06% 174
2025
Q2
$207K Sell
532
-7,157
-93% -$2.88M 0.01% 171
2025
Q1
$3.34M Buy
7,689
+762
+11% +$306K 0.1% 131
2024
Q4
$2.56M Buy
+6,927
New +$2.9M 0.08% 138
2024
Q3
Sell
-864
Closed -$468K 149
2024
Q2
$468K Hold
864
0.04% 121
2024
Q1
$448K Sell
864
-9
-1% -$4.48K 0.03% 124
2023
Q4
$412K Sell
873
-46
-5% -$21.3K 0.03% 123
2023
Q3
$400K Hold
919
0.02% 121
2023
Q2
$408K Sell
919
-17
-2% -$7.84K 0.03% 128
2023
Q1
$430K Sell
936
-9,497
-91% -$4.52M 0.03% 117
2022
Q4
$5.35M Buy
10,433
+81
+0.8% +$41.1K 0.16% 88
2022
Q3
$4.7M Sell
10,352
-101
-1% -$48.3K 0.14% 86
2022
Q2
$5.04M Sell
10,453
-1,300
-11% -$643K 0.16% 92
2022
Q1
$5.77M Sell
11,753
-8,448
-42% -$3.86M 0.15% 92
2021
Q4
$9.36M Buy
20,201
+14,327
+244% +$6.03M 0.18% 90
2021
Q3
$2.19M Sell
5,874
-536
-8% -$204K 0.09% 116
2021
Q2
$2.45M Sell
6,410
-476
-7% -$182K 0.08% 103
2021
Q1
$2.47M Buy
6,886
+868
+14% +$279K 0.08% 112
2020
Q4
$1.93M Sell
6,018
-506
-8% -$155K 0.06% 136
2020
Q3
$1.75M Sell
6,524
-1,315
-17% -$354K 0.06% 126
2020
Q2
$2.06M Sell
7,839
-1,669
-18% -$445K 0.07% 113
2020
Q1
$2.16M Sell
9,508
-4,251
-31% -$1.16M 0.08% 100
2019
Q4
$4.16M Sell
13,759
-13
-0.1% -$3.58K 0.08% 170
2019
Q3
$3.31M Sell
13,772
-9,302
-40% -$2.55M 0.06% 199
2019
Q2
$6.51M Buy
23,074
+9,425
+69% +$2.57M 0.12% 91
2019
Q1
$3.92M Sell
13,649
-3,907
-22% -$1.13M 0.11% 137
2018
Q4
$4.61M Buy
+17,556
New +$4.83M 0.15% 98
2017
Q3
Sell
-7,719
Closed -$1.45M 103
2017
Q2
$1.45M Buy
+7,719
New +$1.39M 0.08% 130
2017
Q1
Sell
-26,857
Closed -$3.86M 201
2016
Q4
$3.86M Buy
26,857
+15,742
+142% +$2.11M 0.23% 129
2016
Q3
$1.39M Buy
11,115
+8,505
+326% +$1.1M 0.1% 135
2016
Q2
$343K Buy
+2,610
New +$357K 0.02% 158
2015
Q4
Sell
-18,038
Closed -$2.52M 184
2015
Q3
$2.52M Buy
18,038
+2,607
+17% +$392K 0.26% 116
2015
Q2
$2.53M Sell
15,431
-1,825
-11% -$292K 0.23% 96
2015
Q1
$2.66M Buy
+17,256
New +$2.46M 0.22% 138

Other funds holding ELV

Allstate Corporation's ELV Position: Q1 2026 in Review

Allstate Corporation reduced its Elevance Health (ELV) stake by 5.8% in Q1 2026, selling an estimated $322K and leaving 15,857 shares worth $4.64M. The position accounts for 0.05% of the portfolio, ranked #252.

Allstate Corporation first reported a position in ELV in Q1 2015 and has held it in 36 quarters since. The position peaked at $9.36M in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Allstate Corporation held 15,857 shares of Elevance Health worth $4.64M as of Q1 2026.
  • Allstate Corporation sold 980 Elevance Health shares in Q1 2026, an estimated $322K.
  • Elevance Health made up 0.05% of Allstate Corporation's portfolio in Q1 2026, its #252 holding.
  • Allstate Corporation first reported a position in Elevance Health in Q1 2015 and has held it in 36 quarters since.
  • Allstate Corporation's Elevance Health position peaked at $9.36M in Q4 2021.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.